Dr. Noor Nakamura

Pathologist · Hospital La Paz · Spain (ES) · Oncology

Tier 2STK-0011GoodOwner MSL RARachel Adeyemi

Data minimisation

Consent status: Pending. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Thoracic oncology
Disease interests: NSCLC
Scientific interests: Brain metastasesPD-L1 biomarkers
Engagement preference: In person
Advisory boards: 0
Publications: 21
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 2: 2 per year (assumption)

Last engaged: 12 Sept 2026 (3 days ago)
Next planned contact: 14 Mar 2027
Last 6 months vs target: 100%
2 of 1 expected engagements

Insights from this stakeholder (0)

No insights captured from engagements with this stakeholder.

Engagement history (2)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
12 Sept 2026	Congress meeting	Phone	Rachel Adeyemi	Vantrexa	Infusion-reaction management	0	—	Submitted	ENG-0052
12 Apr 2026	Advisory board	Phone	Rachel Adeyemi	Vantrexa	Brain-metastasis subgroup data	0	—	Reviewed	ENG-0081

Timeline

12 Sept 2026
Congress meeting
Infusion-reaction management
12 Apr 2026
Advisory board
Brain-metastasis subgroup data

Related stakeholders (2)

Hospital La Paz

Dr. Zoë Ivanova
Oncology pharmacist
Tier 1
Dr. Ximena Jensen
Primary care physician
Tier 1